DHR

Danaher Corporation

$222.18

-3.33 (-1.48%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 20.11.2025
$254.20
(+14.41%)
Strong Buy: 3
Buy: 17
Hold: 3
Sell: 0
Strong Sell: 0
Description:
Danaher Corporation (DHR) is a leading American diversified conglomerate headquartered in Washington, D.C., renowned for pioneering advancements in Life Sciences, Diagnostics, and Environmental & Applied Solutions. Leveraging cutting-edge technology and a robust portfolio of scientific and diagnostic products, Danaher drives significant improvements in healthcare outcomes and industrial efficiencies globally. With a strong commitment to innovation and operational excellence, the company is well-positioned for sustained growth, continuing to set benchmarks within its core sectors and deliver value to stakeholders.
Exchange:
NYSE
Country:
USA
Sector:
HEALTHCARE
Industry:
DIAGNOSTICS & RESEARCH
Address:
2200 PENNSYLVANIA AVENUE N.W., WASHINGTON, DC, UNITED STATES, 20037-1701
Fiscal year end:
December
Market capitalization:
$161 Billion
EBITDA:
$7.63 Billion
PERatio:
46.31
EPS:
4.87
Dividend per share:
$1.23
Dividend yield:
0.56%
Beta:
0.928

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+259%
How much will you get:
$3,593
Prices dates:
30-10-2015: $59.94 and 31-10-2025: $215.38